Showing results (81-90 of 648) with videos related to
Sort By:
Pageof 65
Neuropharmacology|January 1, 1994
Paradoxical analgesia induced by low doses of naloxone is not potentiated by complete inhibition of enkephalin degradationF Noble, M C Fournié-Zaluski, B P RoquesPharmacology, Biochemistry, and Behavior|March 1, 1991
Effect of a highly selective central CCK-B receptor agonist: BC-264 on rat sleepZ de Saint Hilaire, B P Roques, S NicolaïdisNeuropeptides|January 1, 1986
Investigation on the metabolism of CCK8 analogues by rat brain slicesC Durieux, B Charpentier, D Pelaprat, et al.Nucleic Acids Research|February 11, 1988
Induction of an abortive and futile DNA repair process in E. coli by the antitumor DNA bifunctional intercalator, ditercalinium: role in polA in death inductionB Lambert, B P Roques, J B Le PecqNeuropharmacology|July 31, 1999
Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of ratV Daugé, A Samir, A Cupo, et al.Biochemistry|October 21, 1999
NMR structure of the complex between the zinc finger protein NCp10 of Moloney murine leukemia virus and the single-stranded pentanucleotide d(ACGCC): comparison with HIV-NCp7 complexesW Schüler, C Dong, K Wecker, et al.Neuroreport|July 1, 1993
Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responsesR Maldonado, M Derrien, F Noble, et al.Neuroscience|December 1, 1996
Opposite role of delta 1- and delta 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for delta-opioid receptor heterogeneityF Noble, M C Fournie-Zaluski, B P RoquesNaunyn-Schmiedeberg'S Archives of Pharmacology|November 1, 1995
Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawalR Maldonado, O Valverde, C Garbay, et al.Neuroscience Letters|June 19, 2001
Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphineV Daugé, F Beslot, T Matsui, et al.Pageof 65